Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32ADVAMED HIGHLIGHTS OF 2016 FEBRUARY 18: Board of Directors names Scott Whitaker president and CEO of AdvaMed. MARCH 18: Board of Directors appoints Patrick Daly of Cohera Medical as chairman of AdvaMed Accel. APRIL 6: AdvaMed opens Payment Policy Conference on the challenges of demonstrating medtech’s value in a changing payer world. The event contributed to development of a draft framework for consistent and effective demonstration of value, to support positive coverage and payment decisions. MAY 24: AdvaMed begins Global MedTech Compliance Conference in Dublin, Ireland, in collaboration with MedTech Europe. The event brought together over 300 compliance professionals to discuss global trends, and included a compliance boot camp for emerging small companies. AUGUST 15: Completion of a pro-innovation FDA user fee reauthorization agreement, committing the agency to continued improvements in the efficiency, predictability and transparency of product review processes. The pact includes significant reductions for total review time goals for 510(k)s and PMAs. OCTOBER 1: AdvaMed refocuses its year-long campaign on the medical device tax, pivoting from promoting the benefits of the two-year suspension of the tax, which saves our industry nearly $2 billion annually, to drive a more pointed message on the urgent need for action on full and permanent repeal. OCTOBER 17: Launch of the AdvaMed Purchasing Group to help member companies save on purchases of commonly used goods and services from nationally recognized suppliers. Savings will help provide more resources for R&D, ensure a stronger bottom line, and support companies’ growth and success. OCTOBER 17: Opening of our largest and most successful MedTech Conference ever in Minneapolis. The event drew over 2,650 attendees – 15% greater than last year and 8% above our previous record – including representatives of over 900 companies and stakeholder groups from 27 countries. NOVEMBER 10: AdvaMedDx and the American Clinical Laboratory Association jointly convene the AdvaMedDx-ACLA West Coast Dx Summit in San Diego to spotlight important diagnostics regulatory and reimbursement policy solutions to key challenges, and the value of diagnostics to patient care. NOVEMBER 21: China commits to improving its regulatory system and developing a harmonized approach to unique device identifiers (UDIs) during the U.S.-China Joint Commission on Commerce and Trade meeting. Harmonized UDIs will save our industry about $1 billion in compliance costs. DECEMBER 7: Passage of 21st Century Cures legislation with a robust slate of pro-innovation reforms, including a breakthrough pathway to improve use of FDA’s Expedited Access program. The new law incorporates eight out of 10 of AdvaMed’s priority “Innovation Agenda” regulatory reform proposals. DECEMBER 12: Launch of the AdvaMed Digital sector, dedicated to addressing the unique needs and challenges facing companies in the burgeoning digital health space. AdvaMed Digital will provide specialized expertise for companies at the leading edge of the digital health revolution. DECEMBER 15-16: Based on the China Board’s recommendation, AdvaMed’s Ethics and International Board Committees approve phase-out of direct sponsorships for health care providers to attend third-party educational events under the China Code. We also secured sign-on to the Code from local China device association CAMDI.